Medical Care
Global Opioid Induced Constipation Treatment Market Research Report 2025
- Nov 04, 25
- ID: 489774
- Pages: 91
- Figures: 91
- Views: 15
This report aims to provide a comprehensive presentation of the global market for Opioid Induced Constipation Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Induced Constipation Treatment.
The Opioid Induced Constipation Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Opioid Induced Constipation Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, Route of Administration and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioid Induced Constipation Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda Pharmaceuticals
Bayer
Sanofi
Mallinckrodt
Salix (Bausch Health)
AstraZeneca
Progenics Pharmaceuticals
Purdue Pharm
Nektar Therapeutics
Daiichi Sankyo
Prestige
GSK
Shionogi
Bausch Health
Zentiva
Orifarm A/S
Viatris
Endo International
Zhengdatianqing
Segment by Type
Methylnaltrexone Bromide
Lubiprostone
Naloxegol
Others
Segment Route of Administration
Oral Formulations
Injectable Formulations
Suppositories / Enemas
Other
Segment Mechanism of Action
Peripheral µ-opioid Receptor Antagonists,
Prokinetic Agents
Bulk-forming Laxatives
Other
Segment by Application
Drug Store
Hospital Pharmacies
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, Route of Administration etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioid Induced Constipation Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Opioid Induced Constipation Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Opioid Induced Constipation Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, Route of Administration and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioid Induced Constipation Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda Pharmaceuticals
Bayer
Sanofi
Mallinckrodt
Salix (Bausch Health)
AstraZeneca
Progenics Pharmaceuticals
Purdue Pharm
Nektar Therapeutics
Daiichi Sankyo
Prestige
GSK
Shionogi
Bausch Health
Zentiva
Orifarm A/S
Viatris
Endo International
Zhengdatianqing
Segment by Type
Methylnaltrexone Bromide
Lubiprostone
Naloxegol
Others
Segment Route of Administration
Oral Formulations
Injectable Formulations
Suppositories / Enemas
Other
Segment Mechanism of Action
Peripheral µ-opioid Receptor Antagonists,
Prokinetic Agents
Bulk-forming Laxatives
Other
Segment by Application
Drug Store
Hospital Pharmacies
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, Route of Administration etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioid Induced Constipation Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Induced Constipation Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Methylnaltrexone Bromide
1.2.3 Lubiprostone
1.2.4 Naloxegol
1.2.5 Others
1.3 Market Route of Administration
1.3.1 Global Opioid Induced Constipation Treatment Market Size Growth Rate Route of Administration: 2020 VS 2024 VS 2031
1.3.2 Oral Formulations
1.3.3 Injectable Formulations
1.3.4 Suppositories / Enemas
1.3.5 Other
1.4 Market Mechanism of Action
1.4.1 Global Opioid Induced Constipation Treatment Market Size Growth Rate Mechanism of Action: 2020 VS 2024 VS 2031
1.4.2 Peripheral µ-opioid Receptor Antagonists,
1.4.3 Prokinetic Agents
1.4.4 Bulk-forming Laxatives
1.4.5 Other
1.5 Market by Application
1.5.1 Global Opioid Induced Constipation Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Drug Store
1.5.3 Hospital Pharmacies
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Opioid Induced Constipation Treatment Market Perspective (2020-2031)
2.2 Global Opioid Induced Constipation Treatment Growth Trends by Region
2.2.1 Global Opioid Induced Constipation Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Opioid Induced Constipation Treatment Historic Market Size by Region (2020-2025)
2.2.3 Opioid Induced Constipation Treatment Forecasted Market Size by Region (2026-2031)
2.3 Opioid Induced Constipation Treatment Market Dynamics
2.3.1 Opioid Induced Constipation Treatment Industry Trends
2.3.2 Opioid Induced Constipation Treatment Market Drivers
2.3.3 Opioid Induced Constipation Treatment Market Challenges
2.3.4 Opioid Induced Constipation Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opioid Induced Constipation Treatment Players by Revenue
3.1.1 Global Top Opioid Induced Constipation Treatment Players by Revenue (2020-2025)
3.1.2 Global Opioid Induced Constipation Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Top Opioid Induced Constipation Treatment Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Opioid Induced Constipation Treatment Revenue
3.4 Global Opioid Induced Constipation Treatment Market Concentration Ratio
3.4.1 Global Opioid Induced Constipation Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Induced Constipation Treatment Revenue in 2024
3.5 Global Key Players of Opioid Induced Constipation Treatment Head office and Area Served
3.6 Global Key Players of Opioid Induced Constipation Treatment, Product and Application
3.7 Global Key Players of Opioid Induced Constipation Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioid Induced Constipation Treatment Breakdown Data by Type
4.1 Global Opioid Induced Constipation Treatment Historic Market Size by Type (2020-2025)
4.2 Global Opioid Induced Constipation Treatment Forecasted Market Size by Type (2026-2031)
5 Opioid Induced Constipation Treatment Breakdown Data by Application
5.1 Global Opioid Induced Constipation Treatment Historic Market Size by Application (2020-2025)
5.2 Global Opioid Induced Constipation Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Opioid Induced Constipation Treatment Market Size (2020-2031)
6.2 North America Opioid Induced Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Opioid Induced Constipation Treatment Market Size by Country (2020-2025)
6.4 North America Opioid Induced Constipation Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Opioid Induced Constipation Treatment Market Size (2020-2031)
7.2 Europe Opioid Induced Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Opioid Induced Constipation Treatment Market Size by Country (2020-2025)
7.4 Europe Opioid Induced Constipation Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Opioid Induced Constipation Treatment Market Size (2020-2031)
8.2 Asia-Pacific Opioid Induced Constipation Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Opioid Induced Constipation Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Opioid Induced Constipation Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Opioid Induced Constipation Treatment Market Size (2020-2031)
9.2 Latin America Opioid Induced Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Opioid Induced Constipation Treatment Market Size by Country (2020-2025)
9.4 Latin America Opioid Induced Constipation Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opioid Induced Constipation Treatment Market Size (2020-2031)
10.2 Middle East & Africa Opioid Induced Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Opioid Induced Constipation Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Opioid Induced Constipation Treatment Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceuticals
11.1.1 Takeda Pharmaceuticals Company Details
11.1.2 Takeda Pharmaceuticals Business Overview
11.1.3 Takeda Pharmaceuticals Opioid Induced Constipation Treatment Introduction
11.1.4 Takeda Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.1.5 Takeda Pharmaceuticals Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Opioid Induced Constipation Treatment Introduction
11.2.4 Bayer Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.2.5 Bayer Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Opioid Induced Constipation Treatment Introduction
11.3.4 Sanofi Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.3.5 Sanofi Recent Development
11.4 Mallinckrodt
11.4.1 Mallinckrodt Company Details
11.4.2 Mallinckrodt Business Overview
11.4.3 Mallinckrodt Opioid Induced Constipation Treatment Introduction
11.4.4 Mallinckrodt Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.4.5 Mallinckrodt Recent Development
11.5 Salix (Bausch Health)
11.5.1 Salix (Bausch Health) Company Details
11.5.2 Salix (Bausch Health) Business Overview
11.5.3 Salix (Bausch Health) Opioid Induced Constipation Treatment Introduction
11.5.4 Salix (Bausch Health) Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.5.5 Salix (Bausch Health) Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Opioid Induced Constipation Treatment Introduction
11.6.4 AstraZeneca Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 Progenics Pharmaceuticals
11.7.1 Progenics Pharmaceuticals Company Details
11.7.2 Progenics Pharmaceuticals Business Overview
11.7.3 Progenics Pharmaceuticals Opioid Induced Constipation Treatment Introduction
11.7.4 Progenics Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.7.5 Progenics Pharmaceuticals Recent Development
11.8 Purdue Pharm
11.8.1 Purdue Pharm Company Details
11.8.2 Purdue Pharm Business Overview
11.8.3 Purdue Pharm Opioid Induced Constipation Treatment Introduction
11.8.4 Purdue Pharm Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.8.5 Purdue Pharm Recent Development
11.9 Nektar Therapeutics
11.9.1 Nektar Therapeutics Company Details
11.9.2 Nektar Therapeutics Business Overview
11.9.3 Nektar Therapeutics Opioid Induced Constipation Treatment Introduction
11.9.4 Nektar Therapeutics Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.9.5 Nektar Therapeutics Recent Development
11.10 Daiichi Sankyo
11.10.1 Daiichi Sankyo Company Details
11.10.2 Daiichi Sankyo Business Overview
11.10.3 Daiichi Sankyo Opioid Induced Constipation Treatment Introduction
11.10.4 Daiichi Sankyo Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.10.5 Daiichi Sankyo Recent Development
11.11 Prestige
11.11.1 Prestige Company Details
11.11.2 Prestige Business Overview
11.11.3 Prestige Opioid Induced Constipation Treatment Introduction
11.11.4 Prestige Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.11.5 Prestige Recent Development
11.12 GSK
11.12.1 GSK Company Details
11.12.2 GSK Business Overview
11.12.3 GSK Opioid Induced Constipation Treatment Introduction
11.12.4 GSK Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.12.5 GSK Recent Development
11.13 Shionogi
11.13.1 Shionogi Company Details
11.13.2 Shionogi Business Overview
11.13.3 Shionogi Opioid Induced Constipation Treatment Introduction
11.13.4 Shionogi Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.13.5 Shionogi Recent Development
11.14 Bausch Health
11.14.1 Bausch Health Company Details
11.14.2 Bausch Health Business Overview
11.14.3 Bausch Health Opioid Induced Constipation Treatment Introduction
11.14.4 Bausch Health Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.14.5 Bausch Health Recent Development
11.15 Zentiva
11.15.1 Zentiva Company Details
11.15.2 Zentiva Business Overview
11.15.3 Zentiva Opioid Induced Constipation Treatment Introduction
11.15.4 Zentiva Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.15.5 Zentiva Recent Development
11.16 Orifarm A/S
11.16.1 Orifarm A/S Company Details
11.16.2 Orifarm A/S Business Overview
11.16.3 Orifarm A/S Opioid Induced Constipation Treatment Introduction
11.16.4 Orifarm A/S Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.16.5 Orifarm A/S Recent Development
11.17 Viatris
11.17.1 Viatris Company Details
11.17.2 Viatris Business Overview
11.17.3 Viatris Opioid Induced Constipation Treatment Introduction
11.17.4 Viatris Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.17.5 Viatris Recent Development
11.18 Endo International
11.18.1 Endo International Company Details
11.18.2 Endo International Business Overview
11.18.3 Endo International Opioid Induced Constipation Treatment Introduction
11.18.4 Endo International Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.18.5 Endo International Recent Development
11.19 Zhengdatianqing
11.19.1 Zhengdatianqing Company Details
11.19.2 Zhengdatianqing Business Overview
11.19.3 Zhengdatianqing Opioid Induced Constipation Treatment Introduction
11.19.4 Zhengdatianqing Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.19.5 Zhengdatianqing Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Induced Constipation Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Methylnaltrexone Bromide
1.2.3 Lubiprostone
1.2.4 Naloxegol
1.2.5 Others
1.3 Market Route of Administration
1.3.1 Global Opioid Induced Constipation Treatment Market Size Growth Rate Route of Administration: 2020 VS 2024 VS 2031
1.3.2 Oral Formulations
1.3.3 Injectable Formulations
1.3.4 Suppositories / Enemas
1.3.5 Other
1.4 Market Mechanism of Action
1.4.1 Global Opioid Induced Constipation Treatment Market Size Growth Rate Mechanism of Action: 2020 VS 2024 VS 2031
1.4.2 Peripheral µ-opioid Receptor Antagonists,
1.4.3 Prokinetic Agents
1.4.4 Bulk-forming Laxatives
1.4.5 Other
1.5 Market by Application
1.5.1 Global Opioid Induced Constipation Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Drug Store
1.5.3 Hospital Pharmacies
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Opioid Induced Constipation Treatment Market Perspective (2020-2031)
2.2 Global Opioid Induced Constipation Treatment Growth Trends by Region
2.2.1 Global Opioid Induced Constipation Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Opioid Induced Constipation Treatment Historic Market Size by Region (2020-2025)
2.2.3 Opioid Induced Constipation Treatment Forecasted Market Size by Region (2026-2031)
2.3 Opioid Induced Constipation Treatment Market Dynamics
2.3.1 Opioid Induced Constipation Treatment Industry Trends
2.3.2 Opioid Induced Constipation Treatment Market Drivers
2.3.3 Opioid Induced Constipation Treatment Market Challenges
2.3.4 Opioid Induced Constipation Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opioid Induced Constipation Treatment Players by Revenue
3.1.1 Global Top Opioid Induced Constipation Treatment Players by Revenue (2020-2025)
3.1.2 Global Opioid Induced Constipation Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Top Opioid Induced Constipation Treatment Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Opioid Induced Constipation Treatment Revenue
3.4 Global Opioid Induced Constipation Treatment Market Concentration Ratio
3.4.1 Global Opioid Induced Constipation Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Induced Constipation Treatment Revenue in 2024
3.5 Global Key Players of Opioid Induced Constipation Treatment Head office and Area Served
3.6 Global Key Players of Opioid Induced Constipation Treatment, Product and Application
3.7 Global Key Players of Opioid Induced Constipation Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioid Induced Constipation Treatment Breakdown Data by Type
4.1 Global Opioid Induced Constipation Treatment Historic Market Size by Type (2020-2025)
4.2 Global Opioid Induced Constipation Treatment Forecasted Market Size by Type (2026-2031)
5 Opioid Induced Constipation Treatment Breakdown Data by Application
5.1 Global Opioid Induced Constipation Treatment Historic Market Size by Application (2020-2025)
5.2 Global Opioid Induced Constipation Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Opioid Induced Constipation Treatment Market Size (2020-2031)
6.2 North America Opioid Induced Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Opioid Induced Constipation Treatment Market Size by Country (2020-2025)
6.4 North America Opioid Induced Constipation Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Opioid Induced Constipation Treatment Market Size (2020-2031)
7.2 Europe Opioid Induced Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Opioid Induced Constipation Treatment Market Size by Country (2020-2025)
7.4 Europe Opioid Induced Constipation Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Opioid Induced Constipation Treatment Market Size (2020-2031)
8.2 Asia-Pacific Opioid Induced Constipation Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Opioid Induced Constipation Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Opioid Induced Constipation Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Opioid Induced Constipation Treatment Market Size (2020-2031)
9.2 Latin America Opioid Induced Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Opioid Induced Constipation Treatment Market Size by Country (2020-2025)
9.4 Latin America Opioid Induced Constipation Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opioid Induced Constipation Treatment Market Size (2020-2031)
10.2 Middle East & Africa Opioid Induced Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Opioid Induced Constipation Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Opioid Induced Constipation Treatment Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceuticals
11.1.1 Takeda Pharmaceuticals Company Details
11.1.2 Takeda Pharmaceuticals Business Overview
11.1.3 Takeda Pharmaceuticals Opioid Induced Constipation Treatment Introduction
11.1.4 Takeda Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.1.5 Takeda Pharmaceuticals Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Opioid Induced Constipation Treatment Introduction
11.2.4 Bayer Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.2.5 Bayer Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Opioid Induced Constipation Treatment Introduction
11.3.4 Sanofi Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.3.5 Sanofi Recent Development
11.4 Mallinckrodt
11.4.1 Mallinckrodt Company Details
11.4.2 Mallinckrodt Business Overview
11.4.3 Mallinckrodt Opioid Induced Constipation Treatment Introduction
11.4.4 Mallinckrodt Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.4.5 Mallinckrodt Recent Development
11.5 Salix (Bausch Health)
11.5.1 Salix (Bausch Health) Company Details
11.5.2 Salix (Bausch Health) Business Overview
11.5.3 Salix (Bausch Health) Opioid Induced Constipation Treatment Introduction
11.5.4 Salix (Bausch Health) Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.5.5 Salix (Bausch Health) Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Opioid Induced Constipation Treatment Introduction
11.6.4 AstraZeneca Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 Progenics Pharmaceuticals
11.7.1 Progenics Pharmaceuticals Company Details
11.7.2 Progenics Pharmaceuticals Business Overview
11.7.3 Progenics Pharmaceuticals Opioid Induced Constipation Treatment Introduction
11.7.4 Progenics Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.7.5 Progenics Pharmaceuticals Recent Development
11.8 Purdue Pharm
11.8.1 Purdue Pharm Company Details
11.8.2 Purdue Pharm Business Overview
11.8.3 Purdue Pharm Opioid Induced Constipation Treatment Introduction
11.8.4 Purdue Pharm Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.8.5 Purdue Pharm Recent Development
11.9 Nektar Therapeutics
11.9.1 Nektar Therapeutics Company Details
11.9.2 Nektar Therapeutics Business Overview
11.9.3 Nektar Therapeutics Opioid Induced Constipation Treatment Introduction
11.9.4 Nektar Therapeutics Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.9.5 Nektar Therapeutics Recent Development
11.10 Daiichi Sankyo
11.10.1 Daiichi Sankyo Company Details
11.10.2 Daiichi Sankyo Business Overview
11.10.3 Daiichi Sankyo Opioid Induced Constipation Treatment Introduction
11.10.4 Daiichi Sankyo Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.10.5 Daiichi Sankyo Recent Development
11.11 Prestige
11.11.1 Prestige Company Details
11.11.2 Prestige Business Overview
11.11.3 Prestige Opioid Induced Constipation Treatment Introduction
11.11.4 Prestige Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.11.5 Prestige Recent Development
11.12 GSK
11.12.1 GSK Company Details
11.12.2 GSK Business Overview
11.12.3 GSK Opioid Induced Constipation Treatment Introduction
11.12.4 GSK Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.12.5 GSK Recent Development
11.13 Shionogi
11.13.1 Shionogi Company Details
11.13.2 Shionogi Business Overview
11.13.3 Shionogi Opioid Induced Constipation Treatment Introduction
11.13.4 Shionogi Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.13.5 Shionogi Recent Development
11.14 Bausch Health
11.14.1 Bausch Health Company Details
11.14.2 Bausch Health Business Overview
11.14.3 Bausch Health Opioid Induced Constipation Treatment Introduction
11.14.4 Bausch Health Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.14.5 Bausch Health Recent Development
11.15 Zentiva
11.15.1 Zentiva Company Details
11.15.2 Zentiva Business Overview
11.15.3 Zentiva Opioid Induced Constipation Treatment Introduction
11.15.4 Zentiva Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.15.5 Zentiva Recent Development
11.16 Orifarm A/S
11.16.1 Orifarm A/S Company Details
11.16.2 Orifarm A/S Business Overview
11.16.3 Orifarm A/S Opioid Induced Constipation Treatment Introduction
11.16.4 Orifarm A/S Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.16.5 Orifarm A/S Recent Development
11.17 Viatris
11.17.1 Viatris Company Details
11.17.2 Viatris Business Overview
11.17.3 Viatris Opioid Induced Constipation Treatment Introduction
11.17.4 Viatris Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.17.5 Viatris Recent Development
11.18 Endo International
11.18.1 Endo International Company Details
11.18.2 Endo International Business Overview
11.18.3 Endo International Opioid Induced Constipation Treatment Introduction
11.18.4 Endo International Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.18.5 Endo International Recent Development
11.19 Zhengdatianqing
11.19.1 Zhengdatianqing Company Details
11.19.2 Zhengdatianqing Business Overview
11.19.3 Zhengdatianqing Opioid Induced Constipation Treatment Introduction
11.19.4 Zhengdatianqing Revenue in Opioid Induced Constipation Treatment Business (2020-2025)
11.19.5 Zhengdatianqing Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Opioid Induced Constipation Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Methylnaltrexone Bromide
Table 3. Key Players of Lubiprostone
Table 4. Key Players of Naloxegol
Table 5. Key Players of Others
Table 6. Global Opioid Induced Constipation Treatment Market Size Growth Rate Route of Administration (US$ Million): 2020 VS 2024 VS 2031
Table 7. Key Players of Oral Formulations
Table 8. Key Players of Injectable Formulations
Table 9. Key Players of Suppositories / Enemas
Table 10. Key Players of Other
Table 11. Global Opioid Induced Constipation Treatment Market Size Growth Rate Mechanism of Action (US$ Million): 2020 VS 2024 VS 2031
Table 12. Key Players of Peripheral µ-opioid Receptor Antagonists,
Table 13. Key Players of Prokinetic Agents
Table 14. Key Players of Bulk-forming Laxatives
Table 15. Key Players of Other
Table 16. Global Opioid Induced Constipation Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Opioid Induced Constipation Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Opioid Induced Constipation Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 19. Global Opioid Induced Constipation Treatment Market Share by Region (2020-2025)
Table 20. Global Opioid Induced Constipation Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 21. Global Opioid Induced Constipation Treatment Market Share by Region (2026-2031)
Table 22. Opioid Induced Constipation Treatment Market Trends
Table 23. Opioid Induced Constipation Treatment Market Drivers
Table 24. Opioid Induced Constipation Treatment Market Challenges
Table 25. Opioid Induced Constipation Treatment Market Restraints
Table 26. Global Opioid Induced Constipation Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 27. Global Opioid Induced Constipation Treatment Market Share by Players (2020-2025)
Table 28. Global Top Opioid Induced Constipation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Constipation Treatment as of 2024)
Table 29. Ranking of Global Top Opioid Induced Constipation Treatment Companies by Revenue (US$ Million) in 2024
Table 30. Global 5 Largest Players Market Share by Opioid Induced Constipation Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 31. Global Key Players of Opioid Induced Constipation Treatment, Headquarters and Area Served
Table 32. Global Key Players of Opioid Induced Constipation Treatment, Product and Application
Table 33. Global Key Players of Opioid Induced Constipation Treatment, Date of Enter into This Industry
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Opioid Induced Constipation Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 36. Global Opioid Induced Constipation Treatment Revenue Market Share by Type (2020-2025)
Table 37. Global Opioid Induced Constipation Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 38. Global Opioid Induced Constipation Treatment Revenue Market Share by Type (2026-2031)
Table 39. Global Opioid Induced Constipation Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 40. Global Opioid Induced Constipation Treatment Revenue Market Share by Application (2020-2025)
Table 41. Global Opioid Induced Constipation Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 42. Global Opioid Induced Constipation Treatment Revenue Market Share by Application (2026-2031)
Table 43. North America Opioid Induced Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. North America Opioid Induced Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. North America Opioid Induced Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Europe Opioid Induced Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Europe Opioid Induced Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 48. Europe Opioid Induced Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 49. Asia-Pacific Opioid Induced Constipation Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 50. Asia-Pacific Opioid Induced Constipation Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 51. Asia-Pacific Opioid Induced Constipation Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 52. Latin America Opioid Induced Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 53. Latin America Opioid Induced Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 54. Latin America Opioid Induced Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 55. Middle East & Africa Opioid Induced Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 56. Middle East & Africa Opioid Induced Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 57. Middle East & Africa Opioid Induced Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 58. Takeda Pharmaceuticals Company Details
Table 59. Takeda Pharmaceuticals Business Overview
Table 60. Takeda Pharmaceuticals Opioid Induced Constipation Treatment Product
Table 61. Takeda Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 62. Takeda Pharmaceuticals Recent Development
Table 63. Bayer Company Details
Table 64. Bayer Business Overview
Table 65. Bayer Opioid Induced Constipation Treatment Product
Table 66. Bayer Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 67. Bayer Recent Development
Table 68. Sanofi Company Details
Table 69. Sanofi Business Overview
Table 70. Sanofi Opioid Induced Constipation Treatment Product
Table 71. Sanofi Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 72. Sanofi Recent Development
Table 73. Mallinckrodt Company Details
Table 74. Mallinckrodt Business Overview
Table 75. Mallinckrodt Opioid Induced Constipation Treatment Product
Table 76. Mallinckrodt Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 77. Mallinckrodt Recent Development
Table 78. Salix (Bausch Health) Company Details
Table 79. Salix (Bausch Health) Business Overview
Table 80. Salix (Bausch Health) Opioid Induced Constipation Treatment Product
Table 81. Salix (Bausch Health) Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 82. Salix (Bausch Health) Recent Development
Table 83. AstraZeneca Company Details
Table 84. AstraZeneca Business Overview
Table 85. AstraZeneca Opioid Induced Constipation Treatment Product
Table 86. AstraZeneca Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 87. AstraZeneca Recent Development
Table 88. Progenics Pharmaceuticals Company Details
Table 89. Progenics Pharmaceuticals Business Overview
Table 90. Progenics Pharmaceuticals Opioid Induced Constipation Treatment Product
Table 91. Progenics Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 92. Progenics Pharmaceuticals Recent Development
Table 93. Purdue Pharm Company Details
Table 94. Purdue Pharm Business Overview
Table 95. Purdue Pharm Opioid Induced Constipation Treatment Product
Table 96. Purdue Pharm Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 97. Purdue Pharm Recent Development
Table 98. Nektar Therapeutics Company Details
Table 99. Nektar Therapeutics Business Overview
Table 100. Nektar Therapeutics Opioid Induced Constipation Treatment Product
Table 101. Nektar Therapeutics Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 102. Nektar Therapeutics Recent Development
Table 103. Daiichi Sankyo Company Details
Table 104. Daiichi Sankyo Business Overview
Table 105. Daiichi Sankyo Opioid Induced Constipation Treatment Product
Table 106. Daiichi Sankyo Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 107. Daiichi Sankyo Recent Development
Table 108. Prestige Company Details
Table 109. Prestige Business Overview
Table 110. Prestige Opioid Induced Constipation Treatment Product
Table 111. Prestige Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 112. Prestige Recent Development
Table 113. GSK Company Details
Table 114. GSK Business Overview
Table 115. GSK Opioid Induced Constipation Treatment Product
Table 116. GSK Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 117. GSK Recent Development
Table 118. Shionogi Company Details
Table 119. Shionogi Business Overview
Table 120. Shionogi Opioid Induced Constipation Treatment Product
Table 121. Shionogi Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 122. Shionogi Recent Development
Table 123. Bausch Health Company Details
Table 124. Bausch Health Business Overview
Table 125. Bausch Health Opioid Induced Constipation Treatment Product
Table 126. Bausch Health Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 127. Bausch Health Recent Development
Table 128. Zentiva Company Details
Table 129. Zentiva Business Overview
Table 130. Zentiva Opioid Induced Constipation Treatment Product
Table 131. Zentiva Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 132. Zentiva Recent Development
Table 133. Orifarm A/S Company Details
Table 134. Orifarm A/S Business Overview
Table 135. Orifarm A/S Opioid Induced Constipation Treatment Product
Table 136. Orifarm A/S Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 137. Orifarm A/S Recent Development
Table 138. Viatris Company Details
Table 139. Viatris Business Overview
Table 140. Viatris Opioid Induced Constipation Treatment Product
Table 141. Viatris Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 142. Viatris Recent Development
Table 143. Endo International Company Details
Table 144. Endo International Business Overview
Table 145. Endo International Opioid Induced Constipation Treatment Product
Table 146. Endo International Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 147. Endo International Recent Development
Table 148. Zhengdatianqing Company Details
Table 149. Zhengdatianqing Business Overview
Table 150. Zhengdatianqing Opioid Induced Constipation Treatment Product
Table 151. Zhengdatianqing Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 152. Zhengdatianqing Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Opioid Induced Constipation Treatment Picture
Figure 2. Global Opioid Induced Constipation Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Opioid Induced Constipation Treatment Market Share by Type: 2024 VS 2031
Figure 4. Methylnaltrexone Bromide Features
Figure 5. Lubiprostone Features
Figure 6. Naloxegol Features
Figure 7. Others Features
Figure 8. Global Opioid Induced Constipation Treatment Market Size Comparison Route of Administration (2020-2031) & (US$ Million)
Figure 9. Oral Formulations Features
Figure 10. Injectable Formulations Features
Figure 11. Suppositories / Enemas Features
Figure 12. Other Features
Figure 13. Global Opioid Induced Constipation Treatment Market Size Comparison Mechanism of Action (2020-2031) & (US$ Million)
Figure 14. Peripheral µ-opioid Receptor Antagonists, Features
Figure 15. Prokinetic Agents Features
Figure 16. Bulk-forming Laxatives Features
Figure 17. Other Features
Figure 18. Global Opioid Induced Constipation Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 19. Global Opioid Induced Constipation Treatment Market Share by Application: 2024 VS 2031
Figure 20. Drug Store Case Studies
Figure 21. Hospital Pharmacies Case Studies
Figure 22. Opioid Induced Constipation Treatment Report Years Considered
Figure 23. Global Opioid Induced Constipation Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 24. Global Opioid Induced Constipation Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 25. Global Opioid Induced Constipation Treatment Market Share by Region: 2024 VS 2031
Figure 26. Global Opioid Induced Constipation Treatment Market Share by Players in 2024
Figure 27. Global Opioid Induced Constipation Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. The Top 10 and 5 Players Market Share by Opioid Induced Constipation Treatment Revenue in 2024
Figure 29. North America Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. North America Opioid Induced Constipation Treatment Market Share by Country (2020-2031)
Figure 31. United States Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Canada Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Europe Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Europe Opioid Induced Constipation Treatment Market Share by Country (2020-2031)
Figure 35. Germany Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. France Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. U.K. Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Italy Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Russia Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Ireland Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Opioid Induced Constipation Treatment Market Share by Region (2020-2031)
Figure 43. China Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Japan Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. South Korea Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Southeast Asia Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. India Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Australia & New Zealand Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Latin America Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Latin America Opioid Induced Constipation Treatment Market Share by Country (2020-2031)
Figure 51. Mexico Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Brazil Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Middle East & Africa Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Middle East & Africa Opioid Induced Constipation Treatment Market Share by Country (2020-2031)
Figure 55. Israel Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. UAE Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. Takeda Pharmaceuticals Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 59. Bayer Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 60. Sanofi Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 61. Mallinckrodt Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 62. Salix (Bausch Health) Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 63. AstraZeneca Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 64. Progenics Pharmaceuticals Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 65. Purdue Pharm Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 66. Nektar Therapeutics Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 67. Daiichi Sankyo Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 68. Prestige Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 69. GSK Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 70. Shionogi Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 71. Bausch Health Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 72. Zentiva Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 73. Orifarm A/S Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 74. Viatris Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 75. Endo International Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 76. Zhengdatianqing Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Table 1. Global Opioid Induced Constipation Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Methylnaltrexone Bromide
Table 3. Key Players of Lubiprostone
Table 4. Key Players of Naloxegol
Table 5. Key Players of Others
Table 6. Global Opioid Induced Constipation Treatment Market Size Growth Rate Route of Administration (US$ Million): 2020 VS 2024 VS 2031
Table 7. Key Players of Oral Formulations
Table 8. Key Players of Injectable Formulations
Table 9. Key Players of Suppositories / Enemas
Table 10. Key Players of Other
Table 11. Global Opioid Induced Constipation Treatment Market Size Growth Rate Mechanism of Action (US$ Million): 2020 VS 2024 VS 2031
Table 12. Key Players of Peripheral µ-opioid Receptor Antagonists,
Table 13. Key Players of Prokinetic Agents
Table 14. Key Players of Bulk-forming Laxatives
Table 15. Key Players of Other
Table 16. Global Opioid Induced Constipation Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Opioid Induced Constipation Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Opioid Induced Constipation Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 19. Global Opioid Induced Constipation Treatment Market Share by Region (2020-2025)
Table 20. Global Opioid Induced Constipation Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 21. Global Opioid Induced Constipation Treatment Market Share by Region (2026-2031)
Table 22. Opioid Induced Constipation Treatment Market Trends
Table 23. Opioid Induced Constipation Treatment Market Drivers
Table 24. Opioid Induced Constipation Treatment Market Challenges
Table 25. Opioid Induced Constipation Treatment Market Restraints
Table 26. Global Opioid Induced Constipation Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 27. Global Opioid Induced Constipation Treatment Market Share by Players (2020-2025)
Table 28. Global Top Opioid Induced Constipation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Constipation Treatment as of 2024)
Table 29. Ranking of Global Top Opioid Induced Constipation Treatment Companies by Revenue (US$ Million) in 2024
Table 30. Global 5 Largest Players Market Share by Opioid Induced Constipation Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 31. Global Key Players of Opioid Induced Constipation Treatment, Headquarters and Area Served
Table 32. Global Key Players of Opioid Induced Constipation Treatment, Product and Application
Table 33. Global Key Players of Opioid Induced Constipation Treatment, Date of Enter into This Industry
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Opioid Induced Constipation Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 36. Global Opioid Induced Constipation Treatment Revenue Market Share by Type (2020-2025)
Table 37. Global Opioid Induced Constipation Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 38. Global Opioid Induced Constipation Treatment Revenue Market Share by Type (2026-2031)
Table 39. Global Opioid Induced Constipation Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 40. Global Opioid Induced Constipation Treatment Revenue Market Share by Application (2020-2025)
Table 41. Global Opioid Induced Constipation Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 42. Global Opioid Induced Constipation Treatment Revenue Market Share by Application (2026-2031)
Table 43. North America Opioid Induced Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. North America Opioid Induced Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. North America Opioid Induced Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Europe Opioid Induced Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Europe Opioid Induced Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 48. Europe Opioid Induced Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 49. Asia-Pacific Opioid Induced Constipation Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 50. Asia-Pacific Opioid Induced Constipation Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 51. Asia-Pacific Opioid Induced Constipation Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 52. Latin America Opioid Induced Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 53. Latin America Opioid Induced Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 54. Latin America Opioid Induced Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 55. Middle East & Africa Opioid Induced Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 56. Middle East & Africa Opioid Induced Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 57. Middle East & Africa Opioid Induced Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 58. Takeda Pharmaceuticals Company Details
Table 59. Takeda Pharmaceuticals Business Overview
Table 60. Takeda Pharmaceuticals Opioid Induced Constipation Treatment Product
Table 61. Takeda Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 62. Takeda Pharmaceuticals Recent Development
Table 63. Bayer Company Details
Table 64. Bayer Business Overview
Table 65. Bayer Opioid Induced Constipation Treatment Product
Table 66. Bayer Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 67. Bayer Recent Development
Table 68. Sanofi Company Details
Table 69. Sanofi Business Overview
Table 70. Sanofi Opioid Induced Constipation Treatment Product
Table 71. Sanofi Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 72. Sanofi Recent Development
Table 73. Mallinckrodt Company Details
Table 74. Mallinckrodt Business Overview
Table 75. Mallinckrodt Opioid Induced Constipation Treatment Product
Table 76. Mallinckrodt Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 77. Mallinckrodt Recent Development
Table 78. Salix (Bausch Health) Company Details
Table 79. Salix (Bausch Health) Business Overview
Table 80. Salix (Bausch Health) Opioid Induced Constipation Treatment Product
Table 81. Salix (Bausch Health) Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 82. Salix (Bausch Health) Recent Development
Table 83. AstraZeneca Company Details
Table 84. AstraZeneca Business Overview
Table 85. AstraZeneca Opioid Induced Constipation Treatment Product
Table 86. AstraZeneca Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 87. AstraZeneca Recent Development
Table 88. Progenics Pharmaceuticals Company Details
Table 89. Progenics Pharmaceuticals Business Overview
Table 90. Progenics Pharmaceuticals Opioid Induced Constipation Treatment Product
Table 91. Progenics Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 92. Progenics Pharmaceuticals Recent Development
Table 93. Purdue Pharm Company Details
Table 94. Purdue Pharm Business Overview
Table 95. Purdue Pharm Opioid Induced Constipation Treatment Product
Table 96. Purdue Pharm Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 97. Purdue Pharm Recent Development
Table 98. Nektar Therapeutics Company Details
Table 99. Nektar Therapeutics Business Overview
Table 100. Nektar Therapeutics Opioid Induced Constipation Treatment Product
Table 101. Nektar Therapeutics Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 102. Nektar Therapeutics Recent Development
Table 103. Daiichi Sankyo Company Details
Table 104. Daiichi Sankyo Business Overview
Table 105. Daiichi Sankyo Opioid Induced Constipation Treatment Product
Table 106. Daiichi Sankyo Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 107. Daiichi Sankyo Recent Development
Table 108. Prestige Company Details
Table 109. Prestige Business Overview
Table 110. Prestige Opioid Induced Constipation Treatment Product
Table 111. Prestige Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 112. Prestige Recent Development
Table 113. GSK Company Details
Table 114. GSK Business Overview
Table 115. GSK Opioid Induced Constipation Treatment Product
Table 116. GSK Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 117. GSK Recent Development
Table 118. Shionogi Company Details
Table 119. Shionogi Business Overview
Table 120. Shionogi Opioid Induced Constipation Treatment Product
Table 121. Shionogi Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 122. Shionogi Recent Development
Table 123. Bausch Health Company Details
Table 124. Bausch Health Business Overview
Table 125. Bausch Health Opioid Induced Constipation Treatment Product
Table 126. Bausch Health Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 127. Bausch Health Recent Development
Table 128. Zentiva Company Details
Table 129. Zentiva Business Overview
Table 130. Zentiva Opioid Induced Constipation Treatment Product
Table 131. Zentiva Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 132. Zentiva Recent Development
Table 133. Orifarm A/S Company Details
Table 134. Orifarm A/S Business Overview
Table 135. Orifarm A/S Opioid Induced Constipation Treatment Product
Table 136. Orifarm A/S Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 137. Orifarm A/S Recent Development
Table 138. Viatris Company Details
Table 139. Viatris Business Overview
Table 140. Viatris Opioid Induced Constipation Treatment Product
Table 141. Viatris Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 142. Viatris Recent Development
Table 143. Endo International Company Details
Table 144. Endo International Business Overview
Table 145. Endo International Opioid Induced Constipation Treatment Product
Table 146. Endo International Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 147. Endo International Recent Development
Table 148. Zhengdatianqing Company Details
Table 149. Zhengdatianqing Business Overview
Table 150. Zhengdatianqing Opioid Induced Constipation Treatment Product
Table 151. Zhengdatianqing Revenue in Opioid Induced Constipation Treatment Business (2020-2025) & (US$ Million)
Table 152. Zhengdatianqing Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Opioid Induced Constipation Treatment Picture
Figure 2. Global Opioid Induced Constipation Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Opioid Induced Constipation Treatment Market Share by Type: 2024 VS 2031
Figure 4. Methylnaltrexone Bromide Features
Figure 5. Lubiprostone Features
Figure 6. Naloxegol Features
Figure 7. Others Features
Figure 8. Global Opioid Induced Constipation Treatment Market Size Comparison Route of Administration (2020-2031) & (US$ Million)
Figure 9. Oral Formulations Features
Figure 10. Injectable Formulations Features
Figure 11. Suppositories / Enemas Features
Figure 12. Other Features
Figure 13. Global Opioid Induced Constipation Treatment Market Size Comparison Mechanism of Action (2020-2031) & (US$ Million)
Figure 14. Peripheral µ-opioid Receptor Antagonists, Features
Figure 15. Prokinetic Agents Features
Figure 16. Bulk-forming Laxatives Features
Figure 17. Other Features
Figure 18. Global Opioid Induced Constipation Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 19. Global Opioid Induced Constipation Treatment Market Share by Application: 2024 VS 2031
Figure 20. Drug Store Case Studies
Figure 21. Hospital Pharmacies Case Studies
Figure 22. Opioid Induced Constipation Treatment Report Years Considered
Figure 23. Global Opioid Induced Constipation Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 24. Global Opioid Induced Constipation Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 25. Global Opioid Induced Constipation Treatment Market Share by Region: 2024 VS 2031
Figure 26. Global Opioid Induced Constipation Treatment Market Share by Players in 2024
Figure 27. Global Opioid Induced Constipation Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. The Top 10 and 5 Players Market Share by Opioid Induced Constipation Treatment Revenue in 2024
Figure 29. North America Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. North America Opioid Induced Constipation Treatment Market Share by Country (2020-2031)
Figure 31. United States Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Canada Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Europe Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Europe Opioid Induced Constipation Treatment Market Share by Country (2020-2031)
Figure 35. Germany Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. France Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. U.K. Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Italy Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Russia Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Ireland Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Opioid Induced Constipation Treatment Market Share by Region (2020-2031)
Figure 43. China Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Japan Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. South Korea Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Southeast Asia Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. India Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Australia & New Zealand Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Latin America Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Latin America Opioid Induced Constipation Treatment Market Share by Country (2020-2031)
Figure 51. Mexico Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Brazil Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Middle East & Africa Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Middle East & Africa Opioid Induced Constipation Treatment Market Share by Country (2020-2031)
Figure 55. Israel Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. UAE Opioid Induced Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. Takeda Pharmaceuticals Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 59. Bayer Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 60. Sanofi Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 61. Mallinckrodt Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 62. Salix (Bausch Health) Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 63. AstraZeneca Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 64. Progenics Pharmaceuticals Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 65. Purdue Pharm Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 66. Nektar Therapeutics Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 67. Daiichi Sankyo Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 68. Prestige Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 69. GSK Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 70. Shionogi Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 71. Bausch Health Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 72. Zentiva Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 73. Orifarm A/S Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 74. Viatris Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 75. Endo International Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 76. Zhengdatianqing Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2020-2025)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232